Journal de vascularite

Purpose: The CD40/CD40 ligand (CD40L) system is associated with pathogenic processes of inflammatory diseases, and elevated levels of soluble CD40L have been observed in sera from patients with autoimmune diseases. To determine the diagnostic value of serum-soluble CD40L in Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), we investigated patients with MPO-AAV at various stages of the disease.
Methods: Twenty-eight samples were from patients with active MPO-AAV: 28 samples from inactive-vasculitis patients without infection and 16 samples from inactive-vasculitis patients with infectious complications. Serum soluble CD40L was measured by an enzyme-linked immunosorbent assay. Serum-soluble CD40L was also measured in 15 patients with infectious diseases and in 28 control subjects.
Results: The serum-soluble CD40L level was higher in the patients with inactive vasculitis with infectious complications than in those with inactive vasculitis without infection and the normal control, but there was no significant difference in CD40L levels between the patients with active vasculitis and those with inactive vasculitis with infectious complications. There were significant correlations between the serum levels of soluble CD40L and the serum creatinine and CRP levels. The serum soluble CD40L/creatinine ratio was higher in the inactive vasculitis with infectious complications group than in the active vasculitis group, inactive vasculitis without infection group and the normal control. Comparative receiver-operating-characteristic curves showed that this ratio had 92.8% sensitivity and 96.8% specificity for differentiating patients with infection from those without infection.
Conclusion: Serum-soluble CD40L was not associated with disease activity, but it may be a useful marker for the detection of infectious complications in MPO-AAV.

We report the case of a 64-year-old woman with severe alveolar haemorrhage secondary to granulomatosis with polyangiitis (GPA), who was unknowingly treated with only penicillin and macrolide antibiotics, resulting in successful initial disease remission. The immunomodulatory effects of the macrolide antibiotic used could underlie this novel observation, which may shed new light on the pathogenesis and potential treatment of anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis. The role of macrolides as an adjunct to conventional therapy in cases of AAV with respiratory involvement may be worthy of further investigation.